Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Price:
36.5
USD
1.53%
Market Closed
Market Cap:
$5.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
CA |
|
G
|
Geox SpA
XMUN:GHH
|
IT |
|
O
|
Oculus Inc
OTC:OVTZ
|
CA |
|
H
|
Hilltop Holdings Inc
F:WXF
|
US |
|
A
|
Altair Resources Inc
F:90AA
|
CA |
|
Socionext Inc
OTC:SOCNF
|
JP |
|
O
|
Oracle Corp
XHAM:ORC
|
US |
|
A
|
Adx Energy Ltd
F:GHU
|
AU |
|
L
|
Lightbridge Corp
F:N7ON
|
US |
|
F
|
Fuel Tech Inc
SWB:FUE1
|
US |
|
Hammond Power Solutions Inc
F:T11
|
CA |
Wall St Price Targets
XENE Price Forecast
Based on 20 analysts
Based on 20 analysts
+104% Upside
from
$36.5
today
Xenon Pharmaceuticals Inc (XENE)’s 12-month stock price forecast through October 2027 has a consensus target of $74.46, implying 104% upside. The forecast is based on price targets from 20 Wall Street analysts.
Xenon Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XENE's stock price target?
Price Target
74.46
USD
74.46
USD
According to Wall Street analysts, the average 1-year price target for XENE is 74.46 USD with a low forecast of 46.46 USD and a high forecast of 94.5 USD.
What is the Revenue forecast for Xenon Pharmaceuticals Inc?
Projected CAGR
108%
108%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 8 years is 108%.